These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33786262)

  • 41. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics.
    Polo M; Smith PD; Kim YJ; Wang X; Ko F; Robson MC
    Ann Plast Surg; 1999 Aug; 43(2):185-90. PubMed ID: 10454327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A systematic review of the efficacy, safety and satisfaction of regenerative medicine treatments, including platelet-rich plasma, stromal vascular fraction and stem cell-conditioned medium for hypertrophic scars and keloids.
    Jafarzadeh A; PourMohammad A; Goodarzi A
    Int Wound J; 2024 Apr; 21(4):e14557. PubMed ID: 38126221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epithelial-mesenchymal transition in the formation of hypertrophic scars and keloids.
    Yuan FL; Sun ZL; Feng Y; Liu SY; Du Y; Yu S; Yang ML; Lv GZ
    J Cell Physiol; 2019 Dec; 234(12):21662-21669. PubMed ID: 31106425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intralesional cryotherapy for hypertrophic scars and keloids: a review.
    O'Boyle CP; Shayan-Arani H; Hamada MW
    Scars Burn Heal; 2017; 3():2059513117702162. PubMed ID: 29799581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emerging and Novel Therapies for Keloids: A compendious review.
    Memariani H; Memariani M; Moravvej H; Shahidi-Dadras M
    Sultan Qaboos Univ Med J; 2021 Feb; 21(1):e22-e33. PubMed ID: 33777420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management.
    Wolfram D; Tzankov A; Pülzl P; Piza-Katzer H
    Dermatol Surg; 2009 Feb; 35(2):171-81. PubMed ID: 19215252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Keloid and hypertrophic scars: a review of recent developments in pathogenesis and management.
    Mofikoya BO; Adeyemo WL; Abdus-salam AA
    Nig Q J Hosp Med; 2007; 17(4):134-9. PubMed ID: 18320758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of a silicone gel-filled cushion and silicon gel sheeting for the treatment of hypertrophic or keloid scars.
    Berman B; Flores F
    Dermatol Surg; 1999 Jun; 25(6):484-6. PubMed ID: 10469097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Observational retrospective study evaluating the effects of oral isotretinoin in keloids and hypertrophic scars.
    Guadanhim LR; Gonçalves RG; Bagatin E
    Int J Dermatol; 2016 Nov; 55(11):1255-1258. PubMed ID: 27419807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postoperative radiation protocol for keloids and hypertrophic scars: statistical analysis of 370 sites followed for over 18 months.
    Ogawa R; Miyashita T; Hyakusoku H; Akaishi S; Kuribayashi S; Tateno A
    Ann Plast Surg; 2007 Dec; 59(6):688-91. PubMed ID: 18046154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hyperplastic scars and keloids. Part I: basics and prevention].
    Baisch A; Riedel F
    HNO; 2006 Nov; 54(11):893-904; quiz 905. PubMed ID: 17041777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Keloids and hypertrophic scars.
    Nemeth AJ
    J Dermatol Surg Oncol; 1993 Aug; 19(8):738-46. PubMed ID: 8349914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of verapamil vs triamcinolone acetonide for keloids and hypertrophic scars: A systematic review and meta-analysis.
    Liu R; Yang B; Deng Z; Liu L; Zhao X
    Dermatol Ther; 2020 Jul; 33(4):e13564. PubMed ID: 32400925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Keloids and hypertrophic scars: are they two different sides of the same coin?
    Köse O; Waseem A
    Dermatol Surg; 2008 Mar; 34(3):336-46. PubMed ID: 18177398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Keloid research: current status and future directions.
    Tsai CH; Ogawa R
    Scars Burn Heal; 2019; 5():2059513119868659. PubMed ID: 31452957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative effect and safety of verapamil in keloid and hypertrophic scar treatment: a meta-analysis.
    Li Z; Jin Z
    Ther Clin Risk Manag; 2016; 12():1635-1641. PubMed ID: 27877046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wnt Signaling Pathway Proteins in Scar, Hypertrophic Scar, and Keloid: Evidence for a Continuum?
    Chaudet KM; Goyal A; Veprauskas KR; Nazarian RM
    Am J Dermatopathol; 2020 Nov; 42(11):842-847. PubMed ID: 32310858
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma.
    Akasaka Y; Fujita K; Ishikawa Y; Asuwa N; Inuzuka K; Ishihara M; Ito M; Masuda T; Akishima Y; Zhang L; Ito K; Ishii T
    Wound Repair Regen; 2001; 9(6):501-6. PubMed ID: 11896992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
    Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
    Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methodological quality of clinical trials of keloid scars.
    Morales-Sánchez MA; De Villafranca-Dugelby A; Cruz FJ; Peralta-Pedrero ML
    Cir Cir; 2020; 88(5):591-598. PubMed ID: 33064692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.